Vernalis plc Company Profile (LON:VER)

About Vernalis plc

Vernalis plc logoVernalis plc is a commercial-stage pharmaceutical holding company. The Company is engaged in the research, development and commercialization of pharmaceutical products for a range of medical disorders. The Company has two marketed products: Tuzistra XR in the United States prescription cough cold market, and frovatriptan, an acute treatment for migraine. The Company also has four prescription cough cold products under development, and a pipeline of research and new chemical entity (NCE) development programs. Its commercial pipeline candidates include CCP-05, CCP-06, CCP-07 and CCP-08. The Company operates in the United Kingdom, Rest of Europe, North America and Rest of the World. The Company is also engaged in fragment- and structure-based drug discovery. It has two development products in the central nervous system (CNS) therapeutic area: the fatty acid amide hydrolase (FAAH) inhibitor V158866 for pain, and V81444, an adenosine A2A receptor antagonist as a treatment for CNS diseases.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: VER
  • CUSIP:
Key Metrics:
  • Previous Close: $0.57
  • 50 Day Moving Average: $43.85
  • 200 Day Moving Average: $46.27
  • 52-Week Range: £4,451,230 - GBX 31
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $195.85M
  • Outstanding Shares: 445,123,000
Additional Links:

Analyst Ratings

Consensus Ratings for Vernalis plc (LON:VER) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 80.20

Analysts' Ratings History for Vernalis plc (LON:VER)
Show:
DateFirmActionRatingPrice TargetDetails
9/22/2016Panmure GordonReiterated RatingBuyGBX 76View Rating Details
9/6/2016Stifel NicolausBoost Price TargetBuyGBX 94 -> GBX 99View Rating Details
9/6/2016Canaccord GenuityReiterated RatingBuyGBX 84View Rating Details
7/19/2016Shore CapitalReiterated Ratinghouse stockView Rating Details
12/21/2015N+1 SingerReiterated RatingBuyGBX 86View Rating Details
2/26/2015Oriel Securities LtdReiterated RatingBuyGBX 63View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Vernalis plc (LON:VER)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Vernalis plc (LON:VER)
Current Year EPS Consensus Estimate: $-5.57 EPS

Dividends

Dividend History for Vernalis plc (LON:VER)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Vernalis plc (LON:VER)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/9/2016Mackney,DavidInsiderBuy97,000GBX 45£43,650
5/5/2015Nigel SheailInsiderBuy84,000GBX 59.90£50,316
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vernalis plc (LON:VER)
DateHeadline
capitalcube.com logoVernalis Plc breached its 50 day moving average in a Bullish Manner : VER-GB : September 23, 2016 (LON:VER)
www.capitalcube.com - September 23 at 7:25 AM
biz.yahoo.com logoFull Year 2016 Vernalis PLC Earnings Release - Time Not Supplied (LON:VER)
biz.yahoo.com - September 20 at 7:10 AM
News IconIschemic Cerebral Stroke Market - Emerging Trends and New Technologies Research 2016 - 2024 (LON:VER)
reports.pr-inside.com - September 19 at 7:37 AM
4-traders.com logoVernalis : Notice of Full Year Results (LON:VER)
www.4-traders.com - September 13 at 7:37 AM
publicnow.com logoVernalis plc - Notice of Full Year Results (LON:VER)
www.publicnow.com - September 13 at 7:37 AM
morningstar.co.uk logoVernalis Says New Drug Application For CCP-07 Accepted In US (LON:VER)
www.morningstar.co.uk - September 6 at 8:02 PM
News IconVernalis PLC Release: FDA Accepts CCP-07 NDA For Full Review (LON:VER)
www.biospace.com - September 6 at 8:02 PM
News IconStifel Nicolaus Increases Vernalis plc (VER) Price Target to GBX 99 (LON:VER)
christiannewstoday.com - September 6 at 8:02 PM
capitalcube.com logoVernalis Plc breached its 50 day moving average in a Bearish Manner : VER-GB : September 1, 2016 (LON:VER)
www.capitalcube.com - September 1 at 11:15 AM
capitalcube.com logoVernalis Plc :VER-GB: Earnings Analysis: For the six months ended December 31, 2015 : August 12, 2016 (LON:VER)
www.capitalcube.com - August 12 at 11:25 AM
sbwire.com logoIschemic Cerebral Stroke Market: Regional Markets, Technology Developments and the Competitive Landscape (LON:VER)
www.sbwire.com - August 2 at 8:30 PM
openpr.com logoIschemic Cerebral Stroke Market with Worldwide Industry Analysis to 2024 (LON:VER)
www.openpr.com - August 2 at 7:51 AM
openpr.com logoElectrodes for Medical Devices Market - Emerging Trends and New Technologies Research 2016 - 2024 (LON:VER)
www.openpr.com - August 1 at 7:32 AM
4-traders.com logoVernalis : Reaches Milestone In French Oncology Collaboration (LON:VER)
www.4-traders.com - July 20 at 10:58 AM
finance.yahoo.com logoVernalis Achieves a Milestone in Its Oncology Collaboration With Servier (LON:VER)
finance.yahoo.com - July 19 at 2:00 AM
4-traders.com logoJuno Therapeutics : Vernalis Notes the Acquisition of RedoxTherapies by Juno Therapeutics (LON:VER)
www.4-traders.com - July 18 at 7:43 AM
capitalcube.com logoVernalis Plc breached its 50 day moving average in a Bullish Manner : VER-GB : July 14, 2016 (LON:VER)
www.capitalcube.com - July 14 at 4:39 AM
4-traders.com logoVernalis : Annual Trading In Line With Expectations (LON:VER)
www.4-traders.com - July 9 at 7:17 PM
publicnow.com logoVernalis Announces Successful Completion of CCP-08 Pivotal Multiple-Dose Comparative Bioavailability Study (LON:VER)
www.publicnow.com - July 8 at 2:21 AM
4-traders.com logoVernalis : Year-End Trading Update and Notice of Results (LON:VER)
www.4-traders.com - July 7 at 10:48 AM
morningstar.co.uk logoVernalis Annual Trading In Line With Expectations (LON:VER)
www.morningstar.co.uk - July 7 at 10:48 AM
finance.yahoo.com logoYear-End Trading Update and Notice of Results (LON:VER)
finance.yahoo.com - July 7 at 9:41 AM
breakingfinancenews.com logoVernalis PLC (LON:VER) target price held steady to GBX0 as issued in a report today by Stifel (LON:VER)
breakingfinancenews.com - June 24 at 10:43 AM
News IconAttention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market : Size, Application Analysis, Regional Outlook to 2021 (LON:VER)
www.medgadget.com - June 20 at 9:28 AM
morningstar.co.uk logoDIRECTOR DEALINGS: Vernalis CEO And CFO Buy Shares (LON:VER)
www.morningstar.co.uk - June 9 at 8:42 PM
News IconRenishaw plc (LON:RSW) Given Average Recommendation of "Hold" from Analysts (LON:VER)
wingatewire.com - May 31 at 8:33 PM
uk.finance.yahoo.com logoMoxatag supply issues looming for Vernalis (LON:VER)
uk.finance.yahoo.com - May 19 at 12:56 PM
publicnow.com logoMoxatag Supply Update (LON:VER)
www.publicnow.com - May 19 at 11:32 AM
uk.finance.yahoo.com logoVernalis raises £40m in placing (LON:VER)
uk.finance.yahoo.com - April 25 at 8:15 PM
uk.finance.yahoo.com logoVernalis hires AstraZeneca marketeer to lead Tuzistra operation in US (LON:VER)
uk.finance.yahoo.com - April 21 at 11:21 AM
finance.yahoo.com logoVernalis Announces Successful Completion of CCP-07 Pivotal Multiple-Dose Comparative Bioavailability Study (LON:VER)
finance.yahoo.com - April 14 at 2:00 AM
finance.yahoo.com logoVernalis Announce CCP-08 Single-Dose Study Results (LON:VER)
finance.yahoo.com - April 13 at 2:00 AM
capitalcube.com logoVernalis Plc :VER-GB: Earnings Analysis: For the six months ended December 31, 2015 (LON:VER)
www.capitalcube.com - April 7 at 12:34 PM
uk.finance.yahoo.com logoVernalis drops into red after investment in cough treatment (LON:VER)
uk.finance.yahoo.com - March 17 at 9:58 AM
finance.yahoo.com logoVernalis plc Announces Unaudited Interim Results Announcement for the Six Months Ended 31 December 2015 (LON:VER)
finance.yahoo.com - March 17 at 3:00 AM
4-traders.com logoVernalis plc : half-yearly earnings release (LON:VER)
www.4-traders.com - March 14 at 2:22 PM
capitalcube.com logoVernalis Plc breached its 50 day moving average in a Bearish Manner : VER-GB : March 11, 2016 (LON:VER)
www.capitalcube.com - March 11 at 4:35 AM
capitalcube.com logoVernalis Plc breached its 50 day moving average in a Bullish Manner : VER-GB : March 1, 2016 (LON:VER)
www.capitalcube.com - March 1 at 4:34 AM
finance.yahoo.com logoVernalis plc ("Vernalis" or the "Company") Notice of Results for the Six Months Ended 31 December 2015 (LON:VER)
finance.yahoo.com - February 4 at 11:19 AM
finance.yahoo.com logoAttention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2015 - Research and Markets (LON:VER)
finance.yahoo.com - January 28 at 1:22 PM
noodls.com logoVernalis Announces Adenosine Antagonist Licensee (LON:VER)
www.noodls.com - January 9 at 11:41 AM
capitalcube.com logoVernalis Plc breached its 50 day moving average in a Bearish Manner : January 7, 2016 (LON:VER)
www.capitalcube.com - January 7 at 4:35 AM
noodls.com logoVernalis Announces Corvus Pharmaceuticals, Inc. as its Worldwide Licensee for their Adenosine Antagonist Program (LON:VER)
www.noodls.com - January 6 at 2:17 AM
capitalcube.com logoVernalis Plc breached its 50 day moving average in a Bearish Manner : December 21, 2015 (LON:VER)
www.capitalcube.com - December 21 at 4:33 AM
noodls.com logoVernalis Announces Successful Completion of CCP-07 Pivotal Single-Dose Comparative Bioavailability Study (LON:VER)
www.noodls.com - December 21 at 2:35 AM
noodls.com logoVernalis Announce CCP-07 Single-Dose Study Results (LON:VER)
www.noodls.com - December 21 at 2:13 AM
capitalcube.com logoVernalis Plc breached its 50 day moving average in a Bearish Manner : December 8, 2015 (LON:VER)
www.capitalcube.com - December 8 at 4:34 AM
noodls.com logoLaunch of 2015 Sharesave Plan (LON:VER)
www.noodls.com - December 3 at 12:32 PM
noodls.com logoVernalis Results of Annual General Meeting (LON:VER)
www.noodls.com - December 2 at 6:34 AM
finance.yahoo.com logoVernalis plc ("Vernalis" or the "Company") AGM Statement (LON:VER)
finance.yahoo.com - December 2 at 2:00 AM

Social


Last Updated on 9/25/2016 by MarketBeat.com Staff